Captrust Financial Advisors Corbus Pharmaceuticals Holdings, Inc. Transaction History

Captrust Financial Advisors

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	BUY	$0.6 - $1.11 $150 - $277	250 Added 50.0%	750 $0
Q2 2021 Aug 16, 2021	SELL	$1.39 - $2.21 $347 - $552	-250 Reduced 33.33%	500 $1,000
Q3 2020 Nov 17, 2020	BUY	$1.5 - $9.38 $375 - $2,345	250 Added 50.0%	750 $1,000
Q2 2020 Aug 14, 2020	BUY	$4.79 - $8.39 $2,395 - $4,195	500 New	500 $4,000
Q3 2018 Nov 15, 2018	SELL	$4.65 - $7.95 $11,625 - $19,875	-2,500 Closed	0 $0
Q2 2018 Aug 13, 2018	BUY	$5.05 - $6.8 $12,625 - $17,000	2,500 New	2,500 $13,000

38.7K

Ticker CRBP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 125,268,000
Market Cap $1.22B
Description
Corbus Pharmaceuticals Holdings, Inc., a biopharmaceutical company, focuses on the development of immune modulators for immuno-oncology and fibrosis diseases. It develops lenabasum, an oral molecule that selectively activates cannabinoid receptor type 2 (CB2), which is in Phase II clinical trial to treat systemic lupus erythematosus; CRB-601, an...

Get notified when there are updates to the investment portfolio of Captrust Financial Advisors, based on Form 13F filings with the SEC.

Stay updated on Captrust Financial Advisors with notifications on news.